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As yet there is no generally accepted table for com-
pensation purposes' based, for example on the percentage of
hearing impairment and resultant disability, which might
be calculated by the abovementioned method and related
to the wage a worker was earning at the time of examina-
tion for considering his claim. Although this may be re-
garded as desirable, it is not a medical problem and may
be left to the appropriate authority in each country.
I should like to thank Mr G. V. Meij of the South African
Bureau of Standards, Pretoria, for checking the manuscript.
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A C10mparative Clinical Trial on
*Bantu Psychotic Patients
A. J. VAN WYK, Professor of Psychiatry, University of Pretoria, AND G. F. T. MARAIS, Psychiatric Clinical
Assistant, Weskoppies Hospital, Pretoria
SUMMARY
In a non-blind assessment of 3 neuroleptic drugs, chlor-
promazine (Largactil), thioridazine (Melleril) and c1otia-
pine (Etomine), we found Etomine to be the drug of
choice when the diagnosis is in doubt between a toxic
psychosis or schizophrenia. This drug also offered the
highest discharge rate, 77'7% at 12 weeks compared with
73'5% in the thioridazine group, and 55'5% in the chlor-
promazine group.
No clouding of consciousness was seen in the clotia-
pine group, whereas it was troublesome in the chlorpro-
mazine group in patients having received high parenteral
doses.
'Date received: 26 April 1971.
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No side-effects were seen with thioridazine and extra-
pyramidal side-effects caused by the other two drugs
were easily controlled by dose reduction.
S. Air. Med. J., 45, 945 (1971).
Early in 1968, the drug clotiapine (Etomine, Wander)
became available in South Africa for clinical trials. At that
stage the available literature'" indicated that because of its
quick action, it might be useful in increasing patient turn-
over rate, especially in the Bantu wards where we have a
high admission rate.
It was decided to launch a clinical investigation, com-
paring its effects with chlorpromazine and thioridazine,
two well-known and often used neuroleptics in the Bantu
wards.
TABLE 11. PERCENTAGE PATIENTS DISCHARGED









































remained symptom free for the following 4 weeks, were
they discharged. No patients were discharged on medica-
tion but a letter to the district surgeon stating the treat-
ment which had been received, was given to all discharged
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Figs. 1 and 2 show the differences in action m the two
main diagnostic categories.
It is interesting to note, in the schizophrenic group, a
definite lag in the chlorpromazine curve below the other
two drugs. Also in the toxic group there is a definite lag
in the thioridazine curve below the other two drugs.
When calculating a discharge rate after 12 weeks treat-






Treatment Schizophrenia Toxic Total
psychosis
Clotiapine
(Etomine) 28 8 36
Thioridazine
(Melleril) 21 10 31
Chlorpromazine
(Largactil) 25 9 34
All patients received an initial maximum recommended
dose of each drug. Dosage was reduced when improve-
ment or side-effects began to occur.
Ootiapine: 40 mg t.d.s. oraUy. Because of restlessness
and agitation in 11 patients the initial treatment was
limited to a single dose on the first day (120 mg), given
intravenously, to be followed only on the second day with
the normal daily dosage orally.
Chlorpromazine: 200 mg t.d.s. oraUy. Due to agitation
and restlessness, 4 patients received an initial dose of 100
mg intramuscularly, followed after 8 hours and 16 hours
with oral medication, to make up the total daily dosage of
600 mg.
Thioridazine: 200 mg t.d.s. oraUy. 10 patients received
300 mg t.d.s. on the first day to alleviate agitatiQn and
restlessness.
Medication was discontinued when patients rated 'symp-
tom free' for 2 consecutive weeks, and only when they
Because of the administrative and staff shortage problems
we could not introduce any 'blind' procedures into the
trial. However, we hoped that by using a fair number of
patients and following them through until discharge, we
might nevertheless be able to gather enough data for a
global evaluation of the 3 drugs.
All patients were physically healthy adult Bantu males
suffering from acute psychoses. No epileptic or depressive
psychoses were included and on subsequent analysis it
was found needful to divide all patients into two broad
diagnostic groups, e.g. schizophrenia and toxic psychosis
(Table I).
Dosage
Allocation to either of the 3 drug groups was at random
and all patients were handled by the same staff and the
same clinical investigator throughout the trial. Diagnoses
were confirmed before final diagnostic grouping.
Psychosis ratings were done before treatment and there-
after weekly for 12 weeks or until discharge. The psychosis
rating scale was a very simplified tabulation of the usual
important psychiatric signs and symptoms with which
Bantu patients present. All patients were scored from 1
(normal) through 5 (severely disordered) on 5 diagnostic
criteria, e.g. orientation~ insight, delusions, hallucinations
and general behaviour.
No patients received concurrent electroconvulsive or
antiparkinsonism therapy during the trial.
METHOD
TABLE I. NUMBER OF PATIENTS
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DISCUSSION
The total rating of all symptoms before beginning treat-
ment (x) was computed for each patient. In addition, their
total rating of all symptoms after 1, 2 and more weeks of
observation in hospital was determined. (yi, i = 1, 2, ....).
To obtain the measure of improvement under drug therapy
(x - iy).lOO
we computed the rate Zi = . In the graphs
x ~ 5
are represented the mean values of Zi computed from all
patients observed in week 1. The differences between mean
values Zi of the 3 drug groups were then tested by Student's
I-test. The small numbers at the beginning and at the
end of the curves represent the number of patients from
which the mean was computed.
This method has the disadvantage that patients who are
cured and discharged from hospital fall out of the cal-
culation. Their ratings after discharge are not known, and
it would be wrong to assess them with the minimal rating
for all following weeks. So those discharged early have
a negative influence upon the improvement-curves. How-
ever, this factor remains approximately the same for all
drug groups.
In the schizophrenic group a general tendency for each
drug is apparent in Fig. 1, although statistically there are
no significant differences. This can be explained by the fact
that at 9 weeks and longer, the numbers of patients in
each group were too small.
In the toxic psychosis group statistically significant
differences (at the level 2a = 0'05) were found between
the groups chlorpromazine--clothiapine and chlorproma-
zine-thioridazine.
Taking into consideration the large number of Bantu
patients admitted in a toxic state with an underlying
schizophrenia discovered only when toxicity is clearing up,
we think that the clotiapine would be an ideal neuro-
leptic to increase our patient turnover rate. This con-
clusion is reinforced by Figs. 1 and 2, where it is evident
that clothiapine (Etomine, Wander) gives rapid response in
both schizophrenia and toxic psychoses. By using either of
the other two drugs at the time when exact diagnosis is
still in doubt, one might find an unsatisfactory response.
Furthermore, an advantage of clotiapine over the
other two drugs is the availability of a safe parenteral
solution. In none of the 11 patients treated with 120 mg
clotiapine intravenously did we notice untoward clinical
side-effects either locally or systemically. They all promptly
calmed down and were put to bed.
We did notice an upsetting degree of mental clouding
in all 4 patients 24 hours after the intramuscular chlor-
promazine injection. It was so severe that it was only
with difficulty that any information could be obtained from
them the next day.
This clouding of consciousness was not present at all in
patients that had received clothiapine intravenously the
previous day. Although they were heavily sedated, they
could give a good account and assessment of psychosis
was therefore much easier with them.
No extrapyramidal side-effects were noticed in the
thioridazine group. This is in accordance with the obser-
vations of other workers.'" However, extrapyramidal side-
effects did occur in several patients in the other two groups
but because they were easily controlled by dose-reduction,
we did not find it necessary or practical to rate side-effects
separately.
Because of practical and administrative problems no
follow-up studies could be carried out.
We wish to thank Dr A. Wander S.A., Berne, Switzerland,
for the statistical evaluation and the supplies of Etomine.
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